Papers
3
Total Citations
40
H-Index
2
About
Peter Ostler is a leading clinical researcher in radiation oncology, whose work has fundamentally shaped the evidence base for treating localized prostate cancer. His primary research focus is on comparative effectiveness, specifically using randomized controlled trials to evaluate stereotactic body radiotherapy (SBRT) against surgery. Ostler’s most impactful contribution is the landmark PACE-A trial, an international phase 3 study that directly compared SBRT to robotic prostatectomy. The primary endpoint analysis, published in 2023 and garnering 31 citations, provided critical data on quality-of-life outcomes, helping to resolve long-standing therapeutic equipoise between the two modalities. Beyond this flagship work, Ostler has explored patient acceptance of randomization in clinical trials and the management of high-risk pathological features like pT3b disease following robotic surgery. His research is distinguished by its rigorous methodology and direct clinical applicability, offering patients and clinicians clear, evidence-based guidance for navigating complex treatment decisions. Through the PACE study series, Ostler has established himself as a key architect of modern, randomized evidence in the surgical-radiation debate for prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3